4Heal Technology Receives Exclusive Multi-Million Dollar Pre-Seed Round Investment from Aimei Health Technology II, Setting the Stage for Web3 Health AI New Infrastructure

**January 30** — 4Heal Technology, an innovator in Web3 health AI, today announced it has closed a multi-million-dollar Pre-Seed funding round with a $35 million valuation. The round was exclusively led by Nasdaq-listed Aimei Health Technology II (US:AHJK). Proceeds will focus on three core initiatives: Web3 AI health agents, wearable device DePIN networks, and a decentralized de-identified health data commercialization platform. The goal is to advance health data privacy protection, value circulation, and commercial applications from the underlying architecture. 4Heal is redefining intelligent health management standards. The firm aims to equip every user with an AI health steward that both “deeply understands body language” and “responds to emergency needs in real time” via decentralized technology. While safeguarding personal and family data privacy sovereignty, it seeks to build a sustainable Web3 health AI commercial ecosystem. This deal marks a key expansion of Aimei Health Technology II’s global high-quality health tech asset portfolio. It also establishes 4Heal’s formal international capital channels, forging an effective link between technological innovation and the capital market.